The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...

How many companies will be left standing once consolidation hits the AI in healthcare sector? Which pharma companies are ...

An experimental depression drug that joined the Neurocrine Biosciences pipeline as part of a broader package from Takeda Pharmaceutical failed to meet the main goal of a mid-stage clinical trial. The ...

The Food and Drug Administration will remove black box warnings from hormone replacement therapy (HRT) products, which are often used to treat menopause, the Department of Health and Human Services ...

Provider organizations are continuing to adopt AI tools across their departments and clinics, and ambient documentation startups are facing the challenge of differentiating themselves in a field ...

Every day, Americans benefit from consumer-friendly technology that has radically improved every aspect of their lives. But these benefits have lagged in healthcare due to its distinct complexities ...

Eli Lilly is acquiring Sigilon Therapeutics, its type 1 diabetes partner, in a small deal that could pay out big later if the cell therapy developer achieves goals that show it has overcome an immune ...

Function Health, a membership-based platform that gives consumers access to more than 100 different lab tests, on Tuesday announced the close of a sizable funding round — one that includes about a ...

Digital health funding has remained steady this year, with AI startups increasingly capturing a larger share of venture capital. In the first half of this year, AI-focused startups captured a majority ...

Hair loss caused by alopecia areata now has a new FDA-approved treatment, a third-in-class drug from Sun Pharmaceutical Industries that will compete against commercialized medicines from Eli Lilly and ...

Update: This case was resolved on Sunday evening via a settlement, so the trial never occurred. The attorneys representing Hernandez told MedCity News that he categorically denies the allegations.

The Trump administration’s recent changes to the H-1B visa application process are causing concern among healthcare experts, with many worried that the plan could make the industry’s workforce crisis ...